Glucocorticoid receptor antagonists for treatment of diabetes
US6436986B1 · kind B1 · utility
18Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 9, 2000 |
| Grant date | Aug 20, 2002 |
| Priority date | — |
| Expiry date | Aug 9, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D311/80
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The instant invention relates to compounds of formula I which are useful as antagonists of the glucocorticoid receptor and for treating diabetes in a mammal. In addition, any glucocorticoid receptor antagonist(s) is useful for the treatment of diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.